Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATP6V1E1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FOXO3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERVK3-1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2AK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEACAM21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZMIZ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOCK11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IPO8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WIPI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on